Experience of European intensive care physicians with infections due to antibiotic-resistant bacteria, 2009.
A survey was performed among European intensive care physicians to obtain information about their perception and experience with selected antibiotic-resistant bacteria. Seventy-eight out of 95 (82%) participants considered having to deal with infections due to antibiotic-resistant bacteria in the intensive care unit where they work was a major or significant problem. Methicillin-resistant Staphylococcus aureus (MRSA) and third-generation cephalosporin-resistant Enterobacteriaceae were the most frequently reported antibiotic-resistant bacteria with 69 (73%) and 67 (71%) participants reporting having treated at least one patient with such an infection during the preceding six months, respectively. Antibiotic-resistant Gram-negative bacteria, including carbapenem-resistant Enterobacteriaceae, were more frequently reported than any selected antibiotic-resistant Gram-positive bacteria, with the exception of MRSA. Fifty (53%) participants declared having treated at least one patient infected with a bacterium totally or almost totally resistant to available antibiotics during the past six months, with 8 participants having treated more than 10 such patients and 13 having treated from 3 to 10 such patients.
Lepape
A
A
Intensive Care Unit, University Hospital Lyon-Sud, Pierre-Bénite, France. alain.lepape@chu-lyon.fr
Monnet
D L
DL
D000900:Anti-Bacterial Agents / Q000494:pharmacology / Q000627:therapeutic use*; D001424:Bacterial Infections / Q000188:drug therapy / Q000453:epidemiology*; D003422:Critical Care / Q000706:statistics & numerical data*; D003625:Data Collection; D024901:Drug Resistance, Multiple, Bacterial; D005060:Europe / Q000453:epidemiology; D016905:Gram-Negative Bacterial Infections / Q000188:drug therapy / Q000453:epidemiology; D006742:Hospital Bed Capacity; D006801:Humans; D007362:Intensive Care Units / Q000706:statistics & numerical data; D055624:Methicillin-Resistant Staphylococcus aureus; D013203:Staphylococcal Infections / Q000188:drug therapy / Q000453:epidemiology
D000900:Anti-Bacterial Agents